Bandingkan Harga & Kinerja Royalindo Investa Wijaya Tbk. (INDO) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Royalindo Investa Wijaya Tbk. dan Organon Pharma Indonesia Tbk.: Royalindo Investa Wijaya Tbk. diperdagangkan di Rp184 (kapitalisasi pasar 819,98 M, volume 24 jam 35,04 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Royalindo Investa Wijaya Tbk. jauh lebih besar — sekitar 7,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INDO | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 819,98 M | 104,4 M |
Volume | 35,04 jt | — |
Lot | 350,41 rb | — |
Perputaran | 6,39 M | — |
Harga Rata-rata | 182,46 | — |
Nilai Transaksi | 6,39 M | — |
Harga Ekuilibrium Indikatif | 184 | — |
Volume Ekuilibrium Indikatif | 15 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Royalindo Investa Wijaya Tbk.
PT Royalindo Investa Wijaya Tbk (the Company) was established based on Notarial Deed No. 19 dated July 6, 2005 of Tse Min Suhardi, S.H., a public notary in Jakarta. The Company started its commercial operations in July 6, 2005.
Selengkapnya di halaman INDO →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
